These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
367 related items for PubMed ID: 2915562
1. Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization. Otani H, Engelman RM, Rousou JA, Breyer RH, Clement R, Prasad R, Klar J, Das DK. J Thorac Cardiovasc Surg; 1989 Feb; 97(2):267-74. PubMed ID: 2915562 [Abstract] [Full Text] [Related]
2. Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers. Otani H, Engelman RM, Rousou JA, Breyer RH, Lemeshow S, Das DK. J Thorac Cardiovasc Surg; 1986 Feb; 91(2):290-5. PubMed ID: 3945096 [Abstract] [Full Text] [Related]
3. Effects of diltiazem cardioplegia on global function, segmental contractility, and the area of necrosis after acute coronary artery occlusion and surgical reperfusion. Melendez FJ, Gharagozloo F, Sun SC, Benfell K, Austin RE, Shemin RJ, Cohn LH. J Thorac Cardiovasc Surg; 1988 Apr; 95(4):613-7. PubMed ID: 3352294 [Abstract] [Full Text] [Related]
4. Studies of controlled reperfusion after ischemia. XX. Reperfusate composition: detrimental effects of initial asanguineous cardioplegic washout after acute coronary occlusion. Acar C, Partington MT, Buckberg GD. J Thorac Cardiovasc Surg; 1991 Feb; 101(2):294-302. PubMed ID: 1992240 [Abstract] [Full Text] [Related]
7. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. Khan TA, Bianchi C, Voisine P, Feng J, Baker J, Hart M, Takahashi M, Stahl G, Sellke FW. J Thorac Cardiovasc Surg; 2004 Oct; 128(4):602-8. PubMed ID: 15457162 [Abstract] [Full Text] [Related]
8. [Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion]. Zhao JL, Yang YJ, You SJ, Jing ZC, Wu YJ, Yang WX, Meng L, Tian Y, Chen JL, Gao RL, Chen ZJ. Zhonghua Yi Xue Za Zhi; 2005 Mar 16; 85(10):679-83. PubMed ID: 15932731 [Abstract] [Full Text] [Related]
9. Moderation of myocardial ischemia reperfusion injury by calcium channel and calmodulin receptor inhibition. Kimura Y, Engelman RM, Rousou J, Flack J, Iyengar J, Das DK. Heart Vessels; 1992 Mar 16; 7(4):189-95. PubMed ID: 1336774 [Abstract] [Full Text] [Related]
10. The effect of oxygen free radical scavengers on the recovery of regional myocardial function after acute coronary occlusion and surgical reperfusion. Gharagozloo F, Melendez FJ, Hein RA, Austin RE, Shemin RJ, DiSesa VJ, Cohn LH. J Thorac Cardiovasc Surg; 1988 Apr 16; 95(4):631-6. PubMed ID: 3352297 [Abstract] [Full Text] [Related]
11. Effects of "duration" of reperfusate administration versus reperfusate "dose" on regional functional, biochemical, and histochemical recovery. Allen BS, Okamoto F, Buckberg GD, Leaf J, Bugyi H. J Thorac Cardiovasc Surg; 1986 Sep 16; 92(3 Pt 2):594-604. PubMed ID: 3747587 [Abstract] [Full Text] [Related]
18. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model. Muraki S, Morris CD, Budde JM, Zhao ZQ, Guyton RA, Vinten-Johansen J. J Thorac Cardiovasc Surg; 2003 Jan 01; 125(1):155-64. PubMed ID: 12538999 [Abstract] [Full Text] [Related]